EAACI guidelines: Anaphylaxis (2021 update)

A Muraro, M Worm, C Alviani, V Cardona… - Allergy, 2022 - Wiley Online Library
Anaphylaxis is a clinical emergency which all healthcare professionals need to be able to
recognize and manage. The European Academy of Allergy and Clinical Immunology …

Recent insights into the mechanisms of anaphylaxis

WW Stevens, M Kraft, SC Eisenbarth - Current opinion in immunology, 2023 - Elsevier
Anaphylaxis is an acute life-threatening systemic allergic reaction that can have a wide
range of clinical manifestations. The most common triggers for anaphylaxis include food …

An update on anaphylaxis and urticaria

M Worm, S Vieths, V Mahler - Journal of Allergy and Clinical Immunology, 2022 - Elsevier
Notable scientific developments have taken place in the field of anaphylaxis and urticaria in
recent years; they are highlighted in this review. Case-control studies, genome-wide …

Anaphylaxis: a 2023 practice parameter update

DBK Golden, J Wang, S Waserman, C Akin… - Annals of Allergy …, 2024 - Elsevier
This practice parameter update focuses on 7 areas in which there are new evidence and
new recommendations. Diagnostic criteria for anaphylaxis have been revised, and patterns …

Different phenotypes of drug‐induced anaphylaxis—Data from the European Anaphylaxis Registry

T Hanschmann, W Francuzik, S Dölle‐Bierke… - Allergy, 2023 - Wiley Online Library
Background Drugs are a frequent cause of severe anaphylactic reactions. Here, we analyze
a large dataset on drug induced anaphylaxis regarding elicitors, risk factors, symptoms, and …

Routine KIT p. D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone

J Šelb, M Rijavec, R Eržen, M Zidarn, P Kopač… - Journal of Allergy and …, 2021 - Elsevier
Background Clonal mast cell disorders and elevated basal serum tryptase (BST) levels with
unknown cause (s) are associated with severe Hymenoptera venom–triggered anaphylaxis …

[HTML][HTML] Serological profiling reveals hsa-miR-451a as a possible biomarker of anaphylaxis

W Francuzik, K Pažur, M Dalke, S Dölle-Bierke… - JCI insight, 2022 - ncbi.nlm.nih.gov
Background There is a need to support the diagnosis of anaphylaxis by objective markers.
miRNAs are promising noncoding RNA species that may serve as serological biomarkers …

β‐blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy

GJ Sturm, SA Herzog, W Aberer, T Alfaya Arias… - Allergy, 2021 - Wiley Online Library
Background There is controversy whether taking β‐blockers or ACE inhibitors (ACEI) is a
risk factor for more severe systemic insect sting reactions (SSR) and whether it increases the …

Anaphylaxis knowledge gaps and future research priorities: a consensus report

TE Dribin, D Schnadower, J Wang… - Journal of Allergy and …, 2022 - Elsevier
Background Despite a better understanding of the epidemiology, pathogenesis, and
management of patients with anaphylaxis, there remain knowledge gaps. Enumerating and …

Fatal and near-fatal anaphylaxis: data from the European Anaphylaxis Registry and National Health Statistics

V Höfer, S Dölle-Bierke, W Francuzik, F Ruëff… - The Journal of Allergy …, 2024 - Elsevier
Background Anaphylaxis is a serious systemic reaction—data on fatal and near-fatal
reactions are limited. Objective To better understand clinical patterns and risks factors of …